US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

2.2900
+0.0500+2.23%

Close Nov 7 16:00 ET

3.28MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avenue Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Avenue Therapeutics Earnings Reports

Avenue Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 16:20 ET

Avenue Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 16:26 ET

Avenue Therapeutics | 10-K: FY2023 Annual Report

Mar 18 16:23 ET

Avenue Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 13, 2023 16:15 ET

Analyst Rating

Updated: Oct 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall